Adjuvant Chemotherapy after Neoadjuvant Chemotherapy and Long-term Outcomes of CAPOX Plus Bevacizumab Followed by TME for High-risk Localized Rectal Cancer

Junichi Nishimura, Masaki Mori(Tokai University), Junichi Hasegawa(Osaka Rosai Hospital), Tsunekazu Mizushima(The University of Osaka), Yuichiro� Doki(Osaka Gakuin University), Takamichi Komori(Osaka International Cancer Institute), Taishi Hata(The University of Osaka), Keigo Yasumasa(Osaka Hospital), Masataka Ikeda(Hyogo Medical University), Chu Matsuda(Osaka International Cancer Institute), Masaki Tsujie(Sakai Municipal Hospital), Masayoshi Yasui(Osaka International Cancer Institute), Shingo Noura(Osaka Rosai Hospital), Tatsushi Shingai(Kinki Central Hospital), Kimimasa Ikeda(Minoh City Hospital), Mamoru Uemura(Osaka International Cancer Institute)
Journal of the Anus Rectum and Colon
July 29, 2020
Cited by 2


Related Papers